Showing 1216 Results
Why Research Methods Matter
You’ve heard the phrase "garbage in, garbage out." The same adage holds true for research: use garbage methods, and you’ll have garbage results. And with the billions of dollars in public and private…
Observational Studies May "Trouble Scientists," But They Are a Necessary Tool
ICYMI, the Wall Street Journal today ran an interesting and lengthy article, "Analytical Trend Troubles Scientists," which outlines the challenges with the design, conduct and analysis of…
The State of Comparative Effectiveness Research and the Environment for Health Care Decision Making (2012)
The National Pharmaceutical Council conducted its second annual survey of key health care stakeholders. 95 percent of respondents said that CER was "somewhat" or "very important" to them or their…
Webinar: Findings from Annual Survey of Health Care Stakeholders
Presented By: Dan Leonard, Dr. Claudia Schur
Making Informed Decisions: Assessing the Strengths and Weaknesses of Study Designs and Analytic Methods for Comparative Effectiveness Research
The purpose of this document is to provide brief descriptions of both experimental and nonexperimental study designs and methods that may be used to address CER study questions.
Pharmaceutical Technology Assessment: Perspectives From Payers
The processes and evidence used in making pharmaceutical coverage decisions vary substantially among US health plan payers. These variations during the pharmaceutical technology assessment (PTA)…
National Pharmaceutical Council 2011 Annual Report
The 2011 Annual Report highlights NPC's research, educational and partnership activities throughout the year.
Setting Priorities for Comparative Effectiveness Research: From Assessing Public Health Benefits to Being Open With the Public
Abstract (from Health Affairs): Medicine’s current evidence base is insufficient for many of the decisions made daily by clinicians, patients, purchasers, and policy makers. The Patient-Centered…